This topic contains a solution. Click here to go to the answer

Author Question: The cutting stock problem can be reformulated to the: a.knapsack problem. b.CPM-PERT problem. ... (Read 136 times)

WhattoUnderstand

  • Hero Member
  • *****
  • Posts: 517
The cutting stock problem can be reformulated to the:
  a.knapsack problem.
  b.CPM-PERT problem.
  c.transportation problem.
  d.maximum flow problem.

Question 2

The product form of the inverse is:
  a.Bk-1-1 = Ek-1Ek-2 ... E1E0.
  b.B1-1 = Ek-1Ek-2 ... E1E0.
  c.B0-1 = Ek-1Ek-2 ... E1E0.
  d.Bk-1 = Ek-1Ek-2 ... E1E0.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

johnharpe

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

correct: a

Answer to Question 2

correct: d




WhattoUnderstand

  • Member
  • Posts: 517
Reply 2 on: Aug 1, 2018
Wow, this really help


bblaney

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library